Industries
Pharma
The Pharma industry is characterized by long research & development cycles and complex Market Access, but once successful, medicines can achieve universal reimbursement.
Biotech
The biotech industry faces largely the same challenges & opportunities as the pharma industry but in addition to this financing rounds and Business Development & Licensing discussions play a pivotal role on the road towards successful Market Access.
Medical Devices
While regulatory approval is typically faster for Medical Devices compared to medicines, Pricing & Reimbursement is typically more complex and fragmented. Market Access for Medical Devices is a dynamic process which needs to be strategically managed throughout the product lifecycle.
e-Health / Digital Health
Market Access pathways for E-Health / Digital Health solutions are emerging and span from pilot projects to regular reimbursement pathways in key markets.
